Clinical Trials Directory

Trials / Completed

CompletedNCT00622791

Propofol Pharmacokinetics and Pharmacodynamics During Cardiopulmonary Bypass

Effects of Cardiopulmonary Bypass on Plasma Propofol Concentrations and Bis Values During Coronary Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Cardiopulmonary bypass (CPB) is known to alter pharmacokinetics (PK) and brain sensitivity to several drugs, including propofol. Few studies, however, have tested if propofol pharmacokinetical alterations observed after CPB could contribute to the increased hypnotic effect of propofol after CPB. This study was designed to test the hypothesis that changes in the PK of propofol contribute to an increase in its hypnotic effects after CPB as evidenced by changes in bispectral index (BIS) values. Twenty undergoing coronary artery bypass graft patients will be allocated in two groups: 1) CPB groups and 2) off-pump coronary artery bypass graft. Bispectral Index values and blood samples for plasma propofol concentration measurements will be collected along the surgery and up to 12 hours in the post-operative period. Plasma propofol concentrations, Bispectral index values and propofol PK will be compared between the groups.

Conditions

Timeline

First posted
2008-02-25
Last updated
2008-02-25

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00622791. Inclusion in this directory is not an endorsement.

Propofol Pharmacokinetics and Pharmacodynamics During Cardiopulmonary Bypass (NCT00622791) · Clinical Trials Directory